NJBEST
New Jersey Better Educational Savings Trust Portfolio holdings
AUM
$38.9M
This Quarter Return
-3.1%
1 Year Return
+5.78%
3 Year Return
+87.02%
5 Year Return
+168.9%
10 Year Return
+244.92%
AUM
$29.9M
AUM Growth
+$29.9M
(-6.2%)
Cap. Flow
+$1.24M
Cap. Flow
% of AUM
4.15%
Top 10 Holdings %
Top 10 Hldgs %
40.4%
Holding
70
New
2
Increased
3
Reduced
–
Closed
5
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$203K |
| 2 |
Deere & Co
DE
|
$200K |
Top Sells
| 1 |
FedEx
FDX
|
$249K |
| 2 |
Prologis
PLD
|
$215K |
| 3 |
Verizon
VZ
|
$214K |
| 4 |
AstraZeneca
AZN
|
$205K |
| 5 |
Nike
NKE
|
$205K |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Healthcare | 18.96% |
| 3 | Financials | 13.49% |
| 4 | Communication Services | 9.48% |
| 5 | Consumer Discretionary | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Truist Financial
TFC
$59.8B
| $230K | 0.77% |
5,292
| – | – |
|
52
Caterpillar
CAT
$194B
| $230K | 0.77% |
1,400
| – | – |
|
53
Danaher
DHR
$143B
| $225K | 0.75% |
870
| – | – |
|
54
Zions Bancorporation
ZION
$8.48B
| $224K | 0.75% |
4,400
| – | – |
|
55
Accenture
ACN
$158B
| $223K | 0.75% |
865
| – | – |
|
56
Texas Instruments
TXN
$178B
| $217K | 0.73% |
1,405
| – | – |
|
57
Honeywell
HON
$136B
| $217K | 0.73% |
1,300
| – | – |
|
58
PepsiCo
PEP
$203B
| $209K | 0.7% |
1,282
| – | – |
|
59
Coca-Cola
KO
$297B
| $205K | 0.69% |
3,666
| – | – |
|
|
60
Vertex Pharmaceuticals
VRTX
$102B
| $203K | 0.68% |
+700
| New | +$203K |
|
61
Abbott
ABT
$230B
| $202K | 0.68% |
2,085
| – | – |
|
|
62
Deere & Co
DE
$127B
| $200K | 0.67% |
+600
| New | +$200K |
|
63
Chubb
CB
$111B
| $200K | 0.67% |
1,100
| – | – |
|
64
AT&T
T
$208B
| $155K | 0.52% |
10,100
| – | – |
|
65
Pitney Bowes
PBI
$2.07B
| $38K | 0.13% |
16,200
| – | – |
|
|
66
Verizon
VZ
$184B
| – | – |
-4,216
| Closed | -$214K |
|
|
67
Prologis
PLD
$103B
| – | – |
-1,830
| Closed | -$215K |
|
|
68
Nike
NKE
$110B
| – | – |
-2,001
| Closed | -$205K |
|
|
69
FedEx
FDX
$53.2B
| – | – |
-1,100
| Closed | -$249K |
|
|
70
AstraZeneca
AZN
$255B
| – | – |
-3,100
| Closed | -$205K |
|